Editorial
doi: 10.1016/j.jacc.2020.03.040.
Low LDL-C Levels: Likely No Short-Term Cognitive Harm
Affiliations
- PMID: 32381159
- DOI: 10.1016/j.jacc.2020.03.040
Item in Clipboard
Editorial
Low LDL-C Levels: Likely No Short-Term Cognitive Harm
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: PCSK9 inhibitor; cholesterol; cognition; lipid-lowering therapies; safety; statin.
Comment on
-
Cognition After Lowering LDL-Cholesterol With Evolocumab.J Am Coll Cardiol. 2020 May 12;75(18):2283-2293. doi: 10.1016/j.jacc.2020.03.039. J Am Coll Cardiol. 2020. PMID: 32381158 Clinical Trial.
Similar articles
-
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Present perspectives and future horizons.Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):853-62. doi: 10.1016/j.numecd.2016.05.006. Epub 2016 May 30. Nutr Metab Cardiovasc Dis. 2016. PMID: 27352986 Review.
-
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol.Pharmacol Ther. 2016 Aug;164:183-94. doi: 10.1016/j.pharmthera.2016.04.011. Epub 2016 Apr 29. Pharmacol Ther. 2016. PMID: 27133571 Review.
-
PCSK9 inhibitors: a non-statin cholesterol-lowering treatment option.Postgrad Med. 2018 Apr;130(3):287-298. doi: 10.1080/00325481.2018.1436843. Epub 2018 Feb 23. Postgrad Med. 2018. PMID: 29411675 Review.
-
Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.J Pharmacol Exp Ther. 2012 Feb;340(2):228-36. doi: 10.1124/jpet.111.187419. Epub 2011 Oct 21. J Pharmacol Exp Ther. 2012. PMID: 22019884
-
Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors.Curr Med Chem. 2020;27(27):4494-4521. doi: 10.2174/0929867326666190827151012. Curr Med Chem. 2020. PMID: 31453780
Cited by
-
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature.Drugs. 2024 Feb;84(2):165-178. doi: 10.1007/s40265-024-01995-9. Epub 2024 Jan 25. Drugs. 2024. PMID: 38267805 Free PMC article. Review.
-
Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist's Perspective.Medicina (Kaunas). 2021 Jun 13;57(6):616. doi: 10.3390/medicina57060616. Medicina (Kaunas). 2021. PMID: 34199243 Free PMC article.
-
Safety and Tolerability of PCSK9 Inhibitors: Current Insights.Clin Pharmacol. 2020 Dec 11;12:191-202. doi: 10.2147/CPAA.S288831. eCollection 2020. Clin Pharmacol. 2020. PMID: 33335431 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
